nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—AOX1—Methotrexate—systemic scleroderma	0.216	0.394	CbGbCtD
Raloxifene—CYP2C8—Mometasone—systemic scleroderma	0.197	0.359	CbGbCtD
Raloxifene—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0784	0.143	CbGbCtD
Raloxifene—HTR2B—cardial valve—systemic scleroderma	0.0377	0.453	CbGeAlD
Raloxifene—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0318	0.0579	CbGbCtD
Raloxifene—CYP3A4—Prednisone—systemic scleroderma	0.0254	0.0463	CbGbCtD
Raloxifene—ESR1—blood vessel—systemic scleroderma	0.00391	0.0469	CbGeAlD
Raloxifene—ESR2—connective tissue—systemic scleroderma	0.00293	0.0351	CbGeAlD
Raloxifene—ESR2—smooth muscle tissue—systemic scleroderma	0.00268	0.0321	CbGeAlD
Raloxifene—CYP19A1—connective tissue—systemic scleroderma	0.00231	0.0277	CbGeAlD
Raloxifene—ESR2—digestive system—systemic scleroderma	0.00211	0.0253	CbGeAlD
Raloxifene—SIGMAR1—smooth muscle tissue—systemic scleroderma	0.00207	0.0249	CbGeAlD
Raloxifene—HTR2B—smooth muscle tissue—systemic scleroderma	0.00207	0.0248	CbGeAlD
Raloxifene—HTR2B—skin of body—systemic scleroderma	0.00204	0.0245	CbGeAlD
Raloxifene—AOX1—digestive system—systemic scleroderma	0.00203	0.0244	CbGeAlD
Raloxifene—ESR1—connective tissue—systemic scleroderma	0.002	0.024	CbGeAlD
Raloxifene—AOX1—tendon—systemic scleroderma	0.00194	0.0232	CbGeAlD
Raloxifene—ESR1—smooth muscle tissue—systemic scleroderma	0.00183	0.022	CbGeAlD
Raloxifene—ESR2—lung—systemic scleroderma	0.00176	0.0212	CbGeAlD
Raloxifene—AOX1—lung—systemic scleroderma	0.0017	0.0204	CbGeAlD
Raloxifene—HTR2B—digestive system—systemic scleroderma	0.00163	0.0196	CbGeAlD
Raloxifene—SIGMAR1—tendon—systemic scleroderma	0.00156	0.0187	CbGeAlD
Raloxifene—HTR2B—tendon—systemic scleroderma	0.00155	0.0186	CbGeAlD
Raloxifene—ESR1—digestive system—systemic scleroderma	0.00145	0.0174	CbGeAlD
Raloxifene—SIGMAR1—lung—systemic scleroderma	0.00137	0.0164	CbGeAlD
Raloxifene—HTR2B—lung—systemic scleroderma	0.00136	0.0164	CbGeAlD
Raloxifene—CYP2B6—skin of body—systemic scleroderma	0.00134	0.016	CbGeAlD
Raloxifene—ESR1—lung—systemic scleroderma	0.00121	0.0145	CbGeAlD
Raloxifene—CYP2B6—digestive system—systemic scleroderma	0.00107	0.0128	CbGeAlD
Raloxifene—CYP2B6—lung—systemic scleroderma	0.000893	0.0107	CbGeAlD
Raloxifene—CYP3A4—digestive system—systemic scleroderma	0.000808	0.00969	CbGeAlD
Raloxifene—Cystitis—Methotrexate—systemic scleroderma	0.000791	0.00215	CcSEcCtD
Raloxifene—Flatulence—Mycophenolic acid—systemic scleroderma	0.000789	0.00214	CcSEcCtD
Raloxifene—Conjunctivitis—Mycophenolate mofetil—systemic scleroderma	0.000786	0.00213	CcSEcCtD
Raloxifene—Urinary tract infection—Mycophenolate mofetil—systemic scleroderma	0.000786	0.00213	CcSEcCtD
Raloxifene—Sweating—Mycophenolate mofetil—systemic scleroderma	0.000775	0.0021	CcSEcCtD
Raloxifene—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000774	0.0021	CcSEcCtD
Raloxifene—Vaginal infection—Methotrexate—systemic scleroderma	0.000773	0.0021	CcSEcCtD
Raloxifene—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00077	0.00209	CcSEcCtD
Raloxifene—Flushing—Lisinopril—systemic scleroderma	0.000769	0.00209	CcSEcCtD
Raloxifene—Sinusitis—Mycophenolate mofetil—systemic scleroderma	0.000758	0.00206	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000757	0.00206	CcSEcCtD
Raloxifene—Myalgia—Azathioprine—systemic scleroderma	0.000756	0.00205	CcSEcCtD
Raloxifene—Arthralgia—Azathioprine—systemic scleroderma	0.000756	0.00205	CcSEcCtD
Raloxifene—Vertigo—Leflunomide—systemic scleroderma	0.000754	0.00205	CcSEcCtD
Raloxifene—Insomnia—Captopril—systemic scleroderma	0.000752	0.00204	CcSEcCtD
Raloxifene—Angiopathy—Lisinopril—systemic scleroderma	0.000751	0.00204	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.000751	0.00204	CcSEcCtD
Raloxifene—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00075	0.00204	CcSEcCtD
Raloxifene—Abdominal pain—Mometasone—systemic scleroderma	0.000748	0.00203	CcSEcCtD
Raloxifene—Body temperature increased—Mometasone—systemic scleroderma	0.000748	0.00203	CcSEcCtD
Raloxifene—Bladder pain—Methotrexate—systemic scleroderma	0.00074	0.00201	CcSEcCtD
Raloxifene—Cough—Leflunomide—systemic scleroderma	0.000732	0.00199	CcSEcCtD
Raloxifene—Dyspepsia—Captopril—systemic scleroderma	0.000731	0.00199	CcSEcCtD
Raloxifene—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.000728	0.00198	CcSEcCtD
Raloxifene—Dizziness—Pentoxifylline—systemic scleroderma	0.000725	0.00197	CcSEcCtD
Raloxifene—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.000722	0.00196	CcSEcCtD
Raloxifene—Infection—Azathioprine—systemic scleroderma	0.00072	0.00196	CcSEcCtD
Raloxifene—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.00072	0.00196	CcSEcCtD
Raloxifene—Vertigo—Mycophenolic acid—systemic scleroderma	0.000719	0.00195	CcSEcCtD
Raloxifene—Syncope—Mycophenolic acid—systemic scleroderma	0.000718	0.00195	CcSEcCtD
Raloxifene—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.000717	0.00195	CcSEcCtD
Raloxifene—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000715	0.00194	CcSEcCtD
Raloxifene—Chest pain—Leflunomide—systemic scleroderma	0.000714	0.00194	CcSEcCtD
Raloxifene—Arthralgia—Leflunomide—systemic scleroderma	0.000714	0.00194	CcSEcCtD
Raloxifene—Myalgia—Leflunomide—systemic scleroderma	0.000714	0.00194	CcSEcCtD
Raloxifene—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.000713	0.00194	CcSEcCtD
Raloxifene—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.000711	0.00193	CcSEcCtD
Raloxifene—Flatulence—Lisinopril—systemic scleroderma	0.00071	0.00193	CcSEcCtD
Raloxifene—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00071	0.00193	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000709	0.00193	CcSEcCtD
Raloxifene—Skin disorder—Azathioprine—systemic scleroderma	0.000704	0.00191	CcSEcCtD
Raloxifene—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000704	0.00191	CcSEcCtD
Raloxifene—Cough—Mycophenolic acid—systemic scleroderma	0.000699	0.0019	CcSEcCtD
Raloxifene—Vomiting—Pentoxifylline—systemic scleroderma	0.000697	0.00189	CcSEcCtD
Raloxifene—Muscle spasms—Lisinopril—systemic scleroderma	0.000693	0.00188	CcSEcCtD
Raloxifene—Rash—Pentoxifylline—systemic scleroderma	0.000691	0.00188	CcSEcCtD
Raloxifene—Dermatitis—Pentoxifylline—systemic scleroderma	0.000691	0.00188	CcSEcCtD
Raloxifene—Headache—Pentoxifylline—systemic scleroderma	0.000687	0.00187	CcSEcCtD
Raloxifene—Diabetes mellitus—Methotrexate—systemic scleroderma	0.000683	0.00186	CcSEcCtD
Raloxifene—Myalgia—Mycophenolic acid—systemic scleroderma	0.000682	0.00185	CcSEcCtD
Raloxifene—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000682	0.00185	CcSEcCtD
Raloxifene—Chest pain—Mycophenolic acid—systemic scleroderma	0.000682	0.00185	CcSEcCtD
Raloxifene—Infection—Leflunomide—systemic scleroderma	0.00068	0.00185	CcSEcCtD
Raloxifene—Gastrointestinal pain—Captopril—systemic scleroderma	0.000679	0.00185	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000677	0.00184	CcSEcCtD
Raloxifene—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000674	0.00183	CcSEcCtD
Raloxifene—Nervous system disorder—Leflunomide—systemic scleroderma	0.000672	0.00182	CcSEcCtD
Raloxifene—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000671	0.00182	CcSEcCtD
Raloxifene—Skin disorder—Leflunomide—systemic scleroderma	0.000665	0.00181	CcSEcCtD
Raloxifene—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000662	0.0018	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000661	0.00179	CcSEcCtD
Raloxifene—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000658	0.00179	CcSEcCtD
Raloxifene—Body temperature increased—Captopril—systemic scleroderma	0.000657	0.00178	CcSEcCtD
Raloxifene—Abdominal pain—Captopril—systemic scleroderma	0.000657	0.00178	CcSEcCtD
Raloxifene—Nausea—Pentoxifylline—systemic scleroderma	0.000651	0.00177	CcSEcCtD
Raloxifene—Infection—Mycophenolic acid—systemic scleroderma	0.000649	0.00176	CcSEcCtD
Raloxifene—Vertigo—Lisinopril—systemic scleroderma	0.000648	0.00176	CcSEcCtD
Raloxifene—Diarrhoea—Mometasone—systemic scleroderma	0.000647	0.00176	CcSEcCtD
Raloxifene—Syncope—Lisinopril—systemic scleroderma	0.000647	0.00176	CcSEcCtD
Raloxifene—Shock—Mycophenolic acid—systemic scleroderma	0.000643	0.00175	CcSEcCtD
Raloxifene—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000641	0.00174	CcSEcCtD
Raloxifene—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00064	0.00174	CcSEcCtD
Raloxifene—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000635	0.00172	CcSEcCtD
Raloxifene—Loss of consciousness—Lisinopril—systemic scleroderma	0.000634	0.00172	CcSEcCtD
Raloxifene—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000632	0.00172	CcSEcCtD
Raloxifene—Cough—Lisinopril—systemic scleroderma	0.000629	0.00171	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000626	0.0017	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000624	0.00169	CcSEcCtD
Raloxifene—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000623	0.00169	CcSEcCtD
Raloxifene—Insomnia—Leflunomide—systemic scleroderma	0.000619	0.00168	CcSEcCtD
Raloxifene—Arthralgia—Lisinopril—systemic scleroderma	0.000614	0.00167	CcSEcCtD
Raloxifene—Myalgia—Lisinopril—systemic scleroderma	0.000614	0.00167	CcSEcCtD
Raloxifene—Chest pain—Lisinopril—systemic scleroderma	0.000614	0.00167	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00061	0.00166	CcSEcCtD
Raloxifene—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000607	0.00165	CcSEcCtD
Raloxifene—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000606	0.00165	CcSEcCtD
Raloxifene—Dyspepsia—Leflunomide—systemic scleroderma	0.000603	0.00164	CcSEcCtD
Raloxifene—Vomiting—Mometasone—systemic scleroderma	0.000602	0.00163	CcSEcCtD
Raloxifene—Rash—Mometasone—systemic scleroderma	0.000597	0.00162	CcSEcCtD
Raloxifene—Dermatitis—Mometasone—systemic scleroderma	0.000596	0.00162	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000595	0.00162	CcSEcCtD
Raloxifene—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000593	0.00161	CcSEcCtD
Raloxifene—Headache—Mometasone—systemic scleroderma	0.000593	0.00161	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000591	0.00161	CcSEcCtD
Raloxifene—Insomnia—Mycophenolic acid—systemic scleroderma	0.000591	0.0016	CcSEcCtD
Raloxifene—Pain—Leflunomide—systemic scleroderma	0.000586	0.00159	CcSEcCtD
Raloxifene—Infection—Lisinopril—systemic scleroderma	0.000585	0.00159	CcSEcCtD
Raloxifene—Shock—Lisinopril—systemic scleroderma	0.000579	0.00157	CcSEcCtD
Raloxifene—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000576	0.00156	CcSEcCtD
Raloxifene—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000575	0.00156	CcSEcCtD
Raloxifene—Abdominal pain—Azathioprine—systemic scleroderma	0.000573	0.00156	CcSEcCtD
Raloxifene—Body temperature increased—Azathioprine—systemic scleroderma	0.000573	0.00156	CcSEcCtD
Raloxifene—Skin disorder—Lisinopril—systemic scleroderma	0.000572	0.00155	CcSEcCtD
Raloxifene—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000569	0.00154	CcSEcCtD
Raloxifene—Diarrhoea—Captopril—systemic scleroderma	0.000569	0.00154	CcSEcCtD
Raloxifene—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000568	0.00154	CcSEcCtD
Raloxifene—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000567	0.00154	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000564	0.00153	CcSEcCtD
Raloxifene—Nausea—Mometasone—systemic scleroderma	0.000562	0.00153	CcSEcCtD
Raloxifene—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00056	0.00152	CcSEcCtD
Raloxifene—Weight increased—Prednisone—systemic scleroderma	0.000559	0.00152	CcSEcCtD
Raloxifene—Pain—Mycophenolic acid—systemic scleroderma	0.000559	0.00152	CcSEcCtD
Raloxifene—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000555	0.00151	CcSEcCtD
Raloxifene—Cough—Mycophenolate mofetil—systemic scleroderma	0.000551	0.0015	CcSEcCtD
Raloxifene—Dizziness—Captopril—systemic scleroderma	0.000549	0.00149	CcSEcCtD
Raloxifene—Depression—Prednisone—systemic scleroderma	0.000546	0.00148	CcSEcCtD
Raloxifene—Body temperature increased—Leflunomide—systemic scleroderma	0.000541	0.00147	CcSEcCtD
Raloxifene—Abdominal pain—Leflunomide—systemic scleroderma	0.000541	0.00147	CcSEcCtD
Raloxifene—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000538	0.00146	CcSEcCtD
Raloxifene—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000538	0.00146	CcSEcCtD
Raloxifene—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000538	0.00146	CcSEcCtD
Raloxifene—Breast disorder—Methotrexate—systemic scleroderma	0.000537	0.00146	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000536	0.00146	CcSEcCtD
Raloxifene—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000534	0.00145	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000534	0.00145	CcSEcCtD
Raloxifene—Insomnia—Lisinopril—systemic scleroderma	0.000532	0.00145	CcSEcCtD
Raloxifene—Vomiting—Captopril—systemic scleroderma	0.000528	0.00143	CcSEcCtD
Raloxifene—Rash—Captopril—systemic scleroderma	0.000524	0.00142	CcSEcCtD
Raloxifene—Dermatitis—Captopril—systemic scleroderma	0.000523	0.00142	CcSEcCtD
Raloxifene—Headache—Captopril—systemic scleroderma	0.000521	0.00141	CcSEcCtD
Raloxifene—Dyspepsia—Lisinopril—systemic scleroderma	0.000518	0.00141	CcSEcCtD
Raloxifene—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000516	0.0014	CcSEcCtD
Raloxifene—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000516	0.0014	CcSEcCtD
Raloxifene—Infection—Mycophenolate mofetil—systemic scleroderma	0.000512	0.00139	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000508	0.00138	CcSEcCtD
Raloxifene—Shock—Mycophenolate mofetil—systemic scleroderma	0.000507	0.00138	CcSEcCtD
Raloxifene—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000506	0.00137	CcSEcCtD
Raloxifene—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000505	0.00137	CcSEcCtD
Raloxifene—Pain—Lisinopril—systemic scleroderma	0.000503	0.00137	CcSEcCtD
Raloxifene—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000501	0.00136	CcSEcCtD
Raloxifene—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000498	0.00135	CcSEcCtD
Raloxifene—Diarrhoea—Azathioprine—systemic scleroderma	0.000496	0.00135	CcSEcCtD
Raloxifene—Nausea—Captopril—systemic scleroderma	0.000494	0.00134	CcSEcCtD
Raloxifene—Connective tissue disorder—Prednisone—systemic scleroderma	0.000483	0.00131	CcSEcCtD
Raloxifene—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000481	0.00131	CcSEcCtD
Raloxifene—Dizziness—Azathioprine—systemic scleroderma	0.00048	0.0013	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00047	0.00128	CcSEcCtD
Raloxifene—Diarrhoea—Leflunomide—systemic scleroderma	0.000469	0.00127	CcSEcCtD
Raloxifene—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000466	0.00127	CcSEcCtD
Raloxifene—Abdominal pain—Lisinopril—systemic scleroderma	0.000465	0.00126	CcSEcCtD
Raloxifene—Body temperature increased—Lisinopril—systemic scleroderma	0.000465	0.00126	CcSEcCtD
Raloxifene—Vomiting—Azathioprine—systemic scleroderma	0.000461	0.00125	CcSEcCtD
Raloxifene—Pneumonia—Methotrexate—systemic scleroderma	0.000461	0.00125	CcSEcCtD
Raloxifene—Rash—Azathioprine—systemic scleroderma	0.000457	0.00124	CcSEcCtD
Raloxifene—Dermatitis—Azathioprine—systemic scleroderma	0.000457	0.00124	CcSEcCtD
Raloxifene—Depression—Methotrexate—systemic scleroderma	0.000457	0.00124	CcSEcCtD
Raloxifene—Flushing—Prednisone—systemic scleroderma	0.000457	0.00124	CcSEcCtD
Raloxifene—Headache—Azathioprine—systemic scleroderma	0.000454	0.00123	CcSEcCtD
Raloxifene—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000454	0.00123	CcSEcCtD
Raloxifene—Dizziness—Leflunomide—systemic scleroderma	0.000453	0.00123	CcSEcCtD
Raloxifene—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000447	0.00121	CcSEcCtD
Raloxifene—Angiopathy—Prednisone—systemic scleroderma	0.000446	0.00121	CcSEcCtD
Raloxifene—Conjunctivitis—Methotrexate—systemic scleroderma	0.000445	0.00121	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000445	0.00121	CcSEcCtD
Raloxifene—Pain—Mycophenolate mofetil—systemic scleroderma	0.000441	0.0012	CcSEcCtD
Raloxifene—Sweating—Methotrexate—systemic scleroderma	0.000439	0.00119	CcSEcCtD
Raloxifene—Vomiting—Leflunomide—systemic scleroderma	0.000435	0.00118	CcSEcCtD
Raloxifene—Dizziness—Mycophenolic acid—systemic scleroderma	0.000432	0.00117	CcSEcCtD
Raloxifene—Rash—Leflunomide—systemic scleroderma	0.000432	0.00117	CcSEcCtD
Raloxifene—Dermatitis—Leflunomide—systemic scleroderma	0.000431	0.00117	CcSEcCtD
Raloxifene—Nausea—Azathioprine—systemic scleroderma	0.000431	0.00117	CcSEcCtD
Raloxifene—Headache—Leflunomide—systemic scleroderma	0.000429	0.00117	CcSEcCtD
Raloxifene—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000422	0.00114	CcSEcCtD
Raloxifene—Vomiting—Mycophenolic acid—systemic scleroderma	0.000415	0.00113	CcSEcCtD
Raloxifene—Rash—Mycophenolic acid—systemic scleroderma	0.000412	0.00112	CcSEcCtD
Raloxifene—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000412	0.00112	CcSEcCtD
Raloxifene—Headache—Mycophenolic acid—systemic scleroderma	0.000409	0.00111	CcSEcCtD
Raloxifene—Pharyngitis—Methotrexate—systemic scleroderma	0.000408	0.00111	CcSEcCtD
Raloxifene—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000408	0.00111	CcSEcCtD
Raloxifene—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000408	0.00111	CcSEcCtD
Raloxifene—Nausea—Leflunomide—systemic scleroderma	0.000407	0.0011	CcSEcCtD
Raloxifene—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000406	0.0011	CcSEcCtD
Raloxifene—Urethral disorder—Methotrexate—systemic scleroderma	0.000403	0.00109	CcSEcCtD
Raloxifene—Diarrhoea—Lisinopril—systemic scleroderma	0.000403	0.00109	CcSEcCtD
Raloxifene—Dizziness—Lisinopril—systemic scleroderma	0.000389	0.00106	CcSEcCtD
Raloxifene—Nausea—Mycophenolic acid—systemic scleroderma	0.000388	0.00105	CcSEcCtD
Raloxifene—Vertigo—Prednisone—systemic scleroderma	0.000385	0.00104	CcSEcCtD
Raloxifene—Syncope—Prednisone—systemic scleroderma	0.000384	0.00104	CcSEcCtD
Raloxifene—Cardiac disorder—Methotrexate—systemic scleroderma	0.000382	0.00104	CcSEcCtD
Raloxifene—Loss of consciousness—Prednisone—systemic scleroderma	0.000376	0.00102	CcSEcCtD
Raloxifene—Vomiting—Lisinopril—systemic scleroderma	0.000374	0.00102	CcSEcCtD
Raloxifene—Angiopathy—Methotrexate—systemic scleroderma	0.000373	0.00101	CcSEcCtD
Raloxifene—Rash—Lisinopril—systemic scleroderma	0.000371	0.00101	CcSEcCtD
Raloxifene—Dermatitis—Lisinopril—systemic scleroderma	0.000371	0.00101	CcSEcCtD
Raloxifene—Headache—Lisinopril—systemic scleroderma	0.000369	0.001	CcSEcCtD
Raloxifene—Arthralgia—Prednisone—systemic scleroderma	0.000365	0.00099	CcSEcCtD
Raloxifene—Myalgia—Prednisone—systemic scleroderma	0.000365	0.00099	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000362	0.000983	CcSEcCtD
Raloxifene—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000353	0.000958	CcSEcCtD
Raloxifene—Nausea—Lisinopril—systemic scleroderma	0.00035	0.000949	CcSEcCtD
Raloxifene—Infection—Prednisone—systemic scleroderma	0.000347	0.000943	CcSEcCtD
Raloxifene—Shock—Prednisone—systemic scleroderma	0.000344	0.000934	CcSEcCtD
Raloxifene—Nervous system disorder—Prednisone—systemic scleroderma	0.000343	0.000931	CcSEcCtD
Raloxifene—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000341	0.000926	CcSEcCtD
Raloxifene—Skin disorder—Prednisone—systemic scleroderma	0.000339	0.000922	CcSEcCtD
Raloxifene—Hyperhidrosis—Prednisone—systemic scleroderma	0.000338	0.000918	CcSEcCtD
Raloxifene—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000328	0.00089	CcSEcCtD
Raloxifene—Rash—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000883	CcSEcCtD
Raloxifene—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000882	CcSEcCtD
Raloxifene—Headache—Mycophenolate mofetil—systemic scleroderma	0.000323	0.000877	CcSEcCtD
Raloxifene—Vertigo—Methotrexate—systemic scleroderma	0.000322	0.000873	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000318	0.000865	CcSEcCtD
Raloxifene—Insomnia—Prednisone—systemic scleroderma	0.000316	0.000858	CcSEcCtD
Raloxifene—Cough—Methotrexate—systemic scleroderma	0.000312	0.000848	CcSEcCtD
Raloxifene—Dyspepsia—Prednisone—systemic scleroderma	0.000308	0.000835	CcSEcCtD
Raloxifene—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000306	0.000832	CcSEcCtD
Raloxifene—Arthralgia—Methotrexate—systemic scleroderma	0.000305	0.000827	CcSEcCtD
Raloxifene—Chest pain—Methotrexate—systemic scleroderma	0.000305	0.000827	CcSEcCtD
Raloxifene—Myalgia—Methotrexate—systemic scleroderma	0.000305	0.000827	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000303	0.000822	CcSEcCtD
Raloxifene—Infection—Methotrexate—systemic scleroderma	0.00029	0.000788	CcSEcCtD
Raloxifene—Nervous system disorder—Methotrexate—systemic scleroderma	0.000286	0.000778	CcSEcCtD
Raloxifene—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000286	0.000777	CcSEcCtD
Raloxifene—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000286	0.000776	CcSEcCtD
Raloxifene—Skin disorder—Methotrexate—systemic scleroderma	0.000284	0.00077	CcSEcCtD
Raloxifene—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000282	0.000767	CcSEcCtD
Raloxifene—Body temperature increased—Prednisone—systemic scleroderma	0.000276	0.00075	CcSEcCtD
Raloxifene—Abdominal pain—Prednisone—systemic scleroderma	0.000276	0.00075	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000266	0.000723	CcSEcCtD
Raloxifene—Insomnia—Methotrexate—systemic scleroderma	0.000264	0.000717	CcSEcCtD
Raloxifene—Dyspepsia—Methotrexate—systemic scleroderma	0.000257	0.000698	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000252	0.000685	CcSEcCtD
Raloxifene—Pain—Methotrexate—systemic scleroderma	0.00025	0.000678	CcSEcCtD
Raloxifene—Diarrhoea—Prednisone—systemic scleroderma	0.000239	0.000649	CcSEcCtD
Raloxifene—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000239	0.000649	CcSEcCtD
Raloxifene—Dizziness—Prednisone—systemic scleroderma	0.000231	0.000628	CcSEcCtD
Raloxifene—Abdominal pain—Methotrexate—systemic scleroderma	0.000231	0.000627	CcSEcCtD
Raloxifene—Body temperature increased—Methotrexate—systemic scleroderma	0.000231	0.000627	CcSEcCtD
Raloxifene—Vomiting—Prednisone—systemic scleroderma	0.000222	0.000603	CcSEcCtD
Raloxifene—Rash—Prednisone—systemic scleroderma	0.00022	0.000598	CcSEcCtD
Raloxifene—Dermatitis—Prednisone—systemic scleroderma	0.00022	0.000598	CcSEcCtD
Raloxifene—Headache—Prednisone—systemic scleroderma	0.000219	0.000595	CcSEcCtD
Raloxifene—Nausea—Prednisone—systemic scleroderma	0.000208	0.000564	CcSEcCtD
Raloxifene—Diarrhoea—Methotrexate—systemic scleroderma	0.0002	0.000543	CcSEcCtD
Raloxifene—Dizziness—Methotrexate—systemic scleroderma	0.000193	0.000525	CcSEcCtD
Raloxifene—Vomiting—Methotrexate—systemic scleroderma	0.000186	0.000504	CcSEcCtD
Raloxifene—Rash—Methotrexate—systemic scleroderma	0.000184	0.0005	CcSEcCtD
Raloxifene—Dermatitis—Methotrexate—systemic scleroderma	0.000184	0.0005	CcSEcCtD
Raloxifene—Headache—Methotrexate—systemic scleroderma	0.000183	0.000497	CcSEcCtD
Raloxifene—Nausea—Methotrexate—systemic scleroderma	0.000173	0.000471	CcSEcCtD
